Immuno-Oncology Drugs Market Report 2022 - Size, Share, Segments, Trends, And Forecast

The global immuno-oncology drugs market report by the business research company identifies the rise in the number of cancer cases across the globe is likely to contribute to the growth of the immune-oncology drugs market.

The global immuno-oncology drugs market is expected to grow from $60.32 billion in 2021 to $70.59 billion in 2022 at a compound annual growth rate (CAGR) of 17.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The immuno-oncology drugs market is expected to reach $120.37 billion in 2026 at a CAGR of 14.3%..

Purchase The Immuno-Oncology Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3455

The regions covered in the immuno-oncology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Major players in the immuno-oncology drugs market are Amgen Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG and AbbVie Inc.

The global immuno-oncology drugs market is segmented -
1) By Type: Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Others
2) By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Prostate Cancer, Bladder Cancer, Others
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes

Request A Sample Of The Immuno-Oncology Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3455&type=smp

The Immuno-Oncology Drugs Market Report Contents Include
1. Executive Summary
2. Immuno-Oncology Drugs Market Characteristics
3. Immuno-Oncology Drugs Market Trends And Strategies
4. Immuno-Oncology Drugs - Macro Economic Scenario
5. Immuno-Oncology Drugs Market Size And Growth
....
27. Immuno-Oncology Drugs Market Competitive Landscape And Company Profiles
28. Immuno-Oncology Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Immuno-Oncology Drugs Market
30. Immuno-Oncology Drugs Market Future Outlook and Potential Analysis
31. Appendix

This report covers the trends and market dynamics of the immuno-oncology drugs market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
TBRC Blog: http://blog.tbrc.info/
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Healthcare Blog: https://healthcareresearchreports.com/

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.